Introduction
Data Extraction 103 Data extraction on the remaining 290 publications was conducted in a duplicate, blinded fashion. 104 A final consensus meeting was held with both investigators to resolve disagreements. A third 105 investigator (D.T.) was available for adjudication but was not needed. Data were extracted using contained information necessary for a study to be reproducible, such as the availability of 108 materials, data, protocols, or analysis scripts (https://osf.io/3nfa5/). The data extracted varied 109 based on the study design, with studies having no empirical data being excluded (e.g., editorials, 110 commentaries [without reanalysis], simulations, news, reviews, and poems) ( Table 1 ). The form 111 also included the 5-year impact factor and that of the most recent year available and expanded 112 the study design options to include cohort studies, case series, secondary analyses, chart reviews, 113 and cross-sectional studies. Funding options were also expanded to include university, hospital, 114 public, private/industry, non-profit, or mixed funding.
116
Evaluation of Open Access Status 117 We evaluated all 300 publications to determine whether they were freely available online 118 through open access. We searched Open Access Button (openaccessbutton.org) with publication 119 titles and DOI numbers. This tool actively searches for the full-text online. If it could not find a 
Evaluation of Replication and Whether Publications Were Included in Research Synthesis
For empirical studies, excluding meta-analysis and commentary with analysis, we searched the 125 Web of Science to determine whether the publication was cited in a replication study, meta-126 analysis, or systematic review. The Web of Science additionally lists information important for 127 our study, such as the country of journal publication, 5-year impact factor (when available), and 128 most recent impact factor. We report descriptive statistics for each of our findings with 95% confidence intervals (95% CIs) 132 using analysis functions within Microsoft Excel. Over half of our included studies (163/294, 55.44%) provided a statement revealing that their 145 study was without a conflict of interest. However, 95 (32.31%) of our included studies did not 146 provide any type of conflict of interest statement. Nearly two-thirds of our studies (185, 62.93%) 147 did not state if or from where they received funding. Among the 109 studies that provided a 148 statement, most did not receive funding (31, 28.44%). Of the 78 studies that did receive funding, 149 most obtained it through public entities (23, 29.49%). Other characteristics of our included 150 studies can be found in Table 2 and Supplementary Table 1 . The only studies that were assessed for reproducibility were those that had empirical data. Thus, 154 115 articles without empirical data were excluded from the initial 294 studies. We also excluded 155 eight case studies and case series because such studies cannot be reproduced. We therefore 156 assessed a total of 171 studies for reproducibility. Of these studies, 163 (95.32%) did not provide 157 a pre-registration statement. Among the 8 studies that provided a pre-registration statement, 4 158 had accessible links to the pre-registration. Nearly all analyzed studies omitted a data availability 159 statement (162/171, 94.74%). Of the 9 studies that provided a data statement, 2 claimed that their 160 data was not available. None of the 7 studies that claimed their data were available provided 161 enough raw data for the study to be reproduced. Similarly, 156 (96.30%) of 162 analyzed studies 162 (excluding meta-analyses) did not provide a material availability statement. Six studies provided 163 a material availability statement; five of these publications included a statement that materials Supplementary Table 1 . 
Discussion
Our study revealed concerning findings regarding the reproducibility of research in urology 171 literature. Only nine studies made statements regarding the availability of data, and only seven of 172 those actually made their data available. Fewer than half of the studies in our sample were 173 available through Open Access Button, and detailed protocols and pre-registration were rare. 174 One trial in our sample was claimed to be a replication of a previous study, but even this 175 publication failed to include any of the reproducibility markers that we assessed. These findings investigators have posited that freely providing these elements invites plagiarism of study design, 186 a major concern with the pressure on researchers to publish while limiting time and funding. The Repeat framework was designed by McIntosh et al [32] to improve reproducibility in 220 research. This easy-to-use checklist can be adapted for most studies. Additionally, the OSF for nearly every type of study, ensure that manuscripts are written in a transparent way, 226 encouraging reproducibility and accurate reporting of findings. [12] Some journals have begun to 227 require the use of reporting guidelines in the studies they publish. [36] [37] [38] 228 229
Our study has both strengths and limitations. Regarding strengths, we applied double data 230 extraction procedures, which is considered a best practice methodology by the systematic review 231 community and is recommended in the Cochrane Handbook for Systematic Reviews of In recent years, some organizations, including Elsevier, have encouraged the submission and 238 publication of replication studies, but they are not yet common in biomedical literature. [45] We 239 did not attempt to contact authors for data availability, analysis scripts, protocols, or any of the 240 other markers of reproducibility. While we may have found these things to be readily available, 241 it is more likely that we would have run up against the familiar issues of low response rate and 
Reproducibility Markers
The Importance of Each Marker in Regards with Transparency and Reproducibility.
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